An assessment of the laboratory network in Ghana: A national-level ATLAS survey (2019-2020) [0.03%]
对冈比亚实验室网络的评估：ATLAS调查（2019-2020年）国家层面报告
Emma E Kploanyi,Joseph Kenu,Benedicta K Atsu et al.
Emma E Kploanyi et al.
Background: Integrated health systems with strong laboratory networks are critical in improving public health. The current study assessed the laboratory network in Ghana and its functionality using the Assessment Tool for...
Alternative methods for calculating percentage haemolysis of red cell concentrates in peripheral blood banks in Sri Lanka [0.03%]
斯里兰卡外周血库红细胞浓缩物溶血率计算的替代方法
Caroline A Fernando,Deklanji T Dissanayake,Uththara I Hewamana et al.
Caroline A Fernando et al.
Background: Haemolysis - one of the major limiting factors of red cell concentrate quality - must be measured as a quality-monitoring requirement. According to international quality standards, percentage haemolysis must b...
Consequences of rpoB mutations missed by the GenoType MTBDR plus assay in a programmatic setting in South Africa [0.03%]
南非防控项目中GenoType MTBDR plus检测漏检rpoB突变的后果分析
Nomonde R Mvelase,Lindiwe P Cele,Ravesh Singh et al.
Nomonde R Mvelase et al.
Background: Rifampicin resistance missed by commercial rapid molecular assays but detected by phenotypic assays may lead to discordant susceptibility results and affect patient management. ...
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda [0.03%]
乌干达临床药理学实验室能力建设的经验：低收入和中等收入国家的能力建设
Denis Omali,Allan Buzibye,Richard Kwizera et al.
Denis Omali et al.
Background: Research and clinical use of clinical pharmacology laboratories are limited in low- and middle-income countries. We describe our experience in building and sustaining laboratory capacity for clinical pharmacol...
Evaluation of Xpert Carba-R for detecting carbapenemase-producing organisms in South Africa [0.03%]
评估Xpert Carba-R检测南非碳青霉烯耐药菌的效果
Sanelisiwe T Duze,Teena Thomas,Tshegofatso Pelego et al.
Sanelisiwe T Duze et al.
This study evaluated the performance of the Xpert Carba-R assay for detecting the five common carbapenemases in carbapenemase-producing organisms in Johannesburg, South Africa between April 2021 and September 2021. The assay demonstrated 98...
Key success factors for the implementation of quality management systems in developing countries [0.03%]
发展中国家实施质量管理体系的关键成功因素
Iryna Tanasiichuk,Olha Karaman,Larysa Natrus
Iryna Tanasiichuk
Background: Despite the tremendous progress made in advancing laboratory medicine in low- and middle-income countries (LMICs), inadequate quality management systems (QMSs) remain a problem and barrier to provision of reli...
Challenges faced by the HIV testing system in low- and middle-income countries [0.03%]
低收入和中等收入国家艾滋病检测系统面临的挑战
Rachel S Kamgaing,Yagai Bouba,Samuel M Sosso et al.
Rachel S Kamgaing et al.
Introduction: Determining the HIV status of some individuals remains challenging due to multidimensional factors such as flaws in diagnostic systems, technological challenges, and viral diversity. This report pinpoints ch...
Symon F Nayupe,Patrick Mbulaje,Steven Munharo et al.
Symon F Nayupe et al.
The COVID-19 pandemic in sub-Saharan Africa: The significance of presumed immune sufficiency [0.03%]
新冠肺炎疫情下的撒哈拉以南非洲：假定的免疫自给自足的意义
Abel O Idowu,Yusuf O Omosun,Joseph U Igietseme et al.
Abel O Idowu et al.
A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in China in 2019 and later ignited a global pandemic. Contrary to expectations, the effect of the pandemic was not as devastating t...
Point-of-care testing: Connecting communities in Africa and ensuring equity in access to health and diagnostics [0.03%]
即时检测：连接非洲社区并确保获得医疗和诊断的公平性
Rajiv T Erasmus
Rajiv T Erasmus